Ahn, Stacy
Nock, Michael R.
Cohen, Jeffrey M.
Funding for this research was provided by:
Yale School of Medicine
Article History
Received: 27 August 2025
Revised: 10 December 2025
Accepted: 21 December 2025
First Online: 5 January 2026
Declarations
:
: Jeffrey M. Cohen serves on a data and safety monitoring board (DSMB) for Advarra and has served as a consultant for Novartis, Takeda, GSK, and Sanofi. Stacy Ahn and Michael R. Nock have no conflicts of interest to disclose.
: The Yale University Institutional Review Board deemed this project to not be human subjects research (IRB# 2000033602).
: Not applicable.